Evolent Health today said it has entered into a definitive agreement to acquire IPG, a technology and services company providing surgical management solutions for musculoskeletal conditions, from TPG Growth, the middle market and growth equity platform of alternative asset firm TPG, for $375 million plus additional contingent consideration of up to $87 million based on performance.
Upon close the IPG team and platform will be integrated into New Century Health. The deal accelerates Evolent’s core strategy to be a leading provider of value-based specialty care solutions, the company said in a press release. Read more.
